Dr. Lal Pathlabs’ Wholly Owned Subsidiary--- PathLabs Unifiers (PUPL) has received approval for the acquisition of further 10% equity stake in its Subsidiary Company i.e. APRL PathLabs (APRL). Object of acquisition is to strengthen the company’s presence in the state of Gujarat, India. Cost of acquisition is around Rs 7.50 Million. Post this acquisition, total equity stake of PUPL in APRL will increase from 70% to 80%. The Board of Directors of the company in their meeting held on January 30, 2023 approved the same.
Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: